PL197550A1 - Sposob wytwarzania nowych pochodnych fenylopiperazyny - Google Patents

Sposob wytwarzania nowych pochodnych fenylopiperazyny

Info

Publication number
PL197550A1
PL197550A1 PL19755077A PL19755077A PL197550A1 PL 197550 A1 PL197550 A1 PL 197550A1 PL 19755077 A PL19755077 A PL 19755077A PL 19755077 A PL19755077 A PL 19755077A PL 197550 A1 PL197550 A1 PL 197550A1
Authority
PL
Poland
Prior art keywords
production
phenylpiperazine derivatives
new
new phenylpiperazine
derivatives
Prior art date
Application number
PL19755077A
Other languages
English (en)
Other versions
PL117466B1 (en
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of PL197550A1 publication Critical patent/PL197550A1/pl
Publication of PL117466B1 publication Critical patent/PL117466B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL1977197550A 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine PL117466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (2)

Publication Number Publication Date
PL197550A1 true PL197550A1 (pl) 1979-05-21
PL117466B1 PL117466B1 (en) 1981-08-31

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977197550A PL117466B1 (en) 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine

Country Status (34)

Country Link
JP (1) JPS52151183A (pl)
AR (2) AR222003A1 (pl)
AT (1) AT355579B (pl)
AU (1) AU514822B2 (pl)
BE (1) BE853899A (pl)
BG (2) BG27746A3 (pl)
CA (1) CA1087617A (pl)
CH (2) CH633009A5 (pl)
CS (1) CS196360B2 (pl)
DD (1) DD129790A5 (pl)
DE (1) DE2717415A1 (pl)
DK (1) DK176177A (pl)
ES (2) ES457988A1 (pl)
FI (1) FI63937C (pl)
FR (1) FR2348925A1 (pl)
GB (1) GB1575904A (pl)
GR (1) GR64084B (pl)
HU (1) HU176820B (pl)
IE (1) IE44730B1 (pl)
IL (1) IL51787A (pl)
LU (1) LU77170A1 (pl)
MX (1) MX4596E (pl)
NL (1) NL7704456A (pl)
NO (1) NO146710C (pl)
NZ (1) NZ183715A (pl)
OA (1) OA05643A (pl)
PH (1) PH14124A (pl)
PL (1) PL117466B1 (pl)
PT (1) PT66452B (pl)
RO (1) RO72831A (pl)
SE (1) SE7704536L (pl)
SU (2) SU664564A3 (pl)
YU (1) YU104477A (pl)
ZA (1) ZA771849B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
WO1995024399A1 (fr) * 1994-03-11 1995-09-14 Yamanouchi Pharmaceutical Co., Ltd. Agoniste de recepteur 5-ht3, nouveau derive de thiazole et intermediaire destine a son obtention
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
CA2644069A1 (en) 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
YU104477A (en) 1983-01-21
NL7704456A (nl) 1977-10-25
DK176177A (da) 1977-10-24
PH14124A (en) 1981-02-26
NO146710B (no) 1982-08-16
FI771287A (pl) 1977-10-24
BE853899A (fr) 1977-10-24
PT66452A (en) 1977-05-01
ES467948A1 (es) 1978-11-01
PT66452B (en) 1979-03-09
DE2717415A1 (de) 1977-11-10
AU2438677A (en) 1978-10-26
RO72831A (ro) 1983-08-03
AR222635A1 (es) 1981-06-15
HU176820B (en) 1981-05-28
AR222003A1 (es) 1981-04-15
GB1575904A (en) 1980-10-01
AT355579B (de) 1980-03-10
IL51787A (en) 1980-02-29
JPS52151183A (en) 1977-12-15
CH633009A5 (en) 1982-11-15
SU727146A3 (ru) 1980-04-05
OA05643A (fr) 1981-04-30
NZ183715A (en) 1980-04-28
MX4596E (es) 1982-06-25
ATA285177A (de) 1979-08-15
AU514822B2 (en) 1981-02-26
ES457988A1 (es) 1978-07-16
IE44730B1 (en) 1982-03-10
CH625802A5 (en) 1981-10-15
CS196360B2 (en) 1980-03-31
FI63937C (fi) 1983-09-12
FI63937B (fi) 1983-05-31
CA1087617A (en) 1980-10-14
NO146710C (no) 1982-11-24
ZA771849B (en) 1978-11-29
PL117466B1 (en) 1981-08-31
BG28055A3 (en) 1980-02-25
LU77170A1 (pl) 1979-01-18
FR2348925B1 (pl) 1980-04-11
IL51787A0 (en) 1977-05-31
GR64084B (en) 1980-01-21
SU664564A3 (ru) 1979-05-25
FR2348925A1 (fr) 1977-11-18
IE44730L (en) 1977-10-23
DD129790A5 (de) 1978-02-08
NO771398L (no) 1977-10-25
SE7704536L (sv) 1977-10-24
RO72831B (ro) 1983-07-30
BG27746A3 (en) 1979-12-12

Similar Documents

Publication Publication Date Title
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
PL100792B1 (pl) Sposob wytwarzania nowych pochodnych tienopirydyny
PL196886A1 (pl) Sposob wytwarzania nowych alkilooksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporynowego
PL194291A1 (pl) Sposob wytwarzania nowych pochodnych glikozoaminy
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL195504A1 (pl) Sposob wytwarzania nowych oksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporanowego
PL201997A1 (pl) Sposob wytwarzania nowych pochodnych aminopropanolu
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL197005A1 (pl) Sposob wytwarzania nowych pochodnych prostaglandyn
PL199603A1 (pl) Sposob wytwarzania nowych pochodnych kwasu pirolokarboksylowego-1
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL196820A1 (pl) Sposob wytwarzania zwiazkow 3-chlorowcometylocefemowych-3
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL197704A1 (pl) Sposob wytwarzania nowych pochodnych indazoliloksy 4-propanoloaminy
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL197550A1 (pl) Sposob wytwarzania nowych pochodnych fenylopiperazyny
PL200449A1 (pl) Sposob wytwarzania nowych pochodnych kwasu benz-acylo-benzimidazolokarboksylowego-2